Tibet Rhodiola Pharmaceutical Holding Co.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Tibet Nuodikang Pharmaceutical Co., Ltd. was founded on July 14, 1999 in the Tibet Autonomous Region and traded online on the Shanghai Stock Exchange on July 21, 1999. It is the first high-tech pharmaceutical listed enterprise in the Tibet Autonomous Region, with the stock name Tibet Pharmaceutical and stock code 600211. Since its establishment, the company has been recognized by the Ministry of Science and Technology as a key high-tech enterprise of the National Torch Plan and a national innovative pilot enterprise; Jointly recognized as a national key leading enterprise in agricultural industrialization by the National Ministry of Agriculture and Rural Affairs and other organizations; The company's graphic trademark, Xiangyuntu, has been recognized as a well-known trademark in China by the State Administration for Industry and Commerce. The company adheres to the concept of "science leads to health, and health leads to the future". Through more than 20 years of development, the company's total assets have reached 3.803 billion yuan, with a net asset attributable to the listed company of 2.63 billion yuan. The company has established three pharmaceutical production bases for biological products, Tibetan medicine products, and traditional Chinese medicine products that meet GMP standards, one Tibetan medicine planting base that meets GAP standards, and a vaccine production base in Shanghai. It has grown into one of the largest and most modern pharmaceutical enterprises in the Tibet Autonomous Region that integrates research and development, production, and sales. The company focuses on the fields of biopharmaceuticals, modern Tibetan medicine, chemical pharmaceuticals, and big health. It has successively established Sichuan Nordicam Weiguang Pharmaceutical Co., Ltd., Chengdu Nordicam Biopharmaceutical Co., Ltd., Tibet Nordicam Tibetan Medicinal Materials Development Co., Ltd., Tibet Nordicam Pharmaceutical Co., Ltd., Hong Kong Tuopriji Pharmaceutical Co., Ltd., Tibet Oxygen Path Big Health Life Sciences Co., Ltd Shanghai Xinhuo Biotechnology Co., Ltd. and seven subsidiary companies. The company's products cover the fields of biopharmaceuticals, Tibetan medicine, traditional Chinese medicine, and chemical medicine. The company has an international first-class level of genetic engineering drug neoactive and products sold in about 40 countries and regions around the world, such as Imdo; Nordicam products using Tibetan medicinal herb Rhodiola as raw material; In addition, the company also has excellent varieties of national Chinese medicine, such as Xueshan Golden Arhat Pain Relieving Coating, Shiwei Dida Capsule, and Xiaoer Shuangqing Granules. |
| Headquarter | Lhasa City |
| Establish Date | 7/14/1999 |
| Listed Code | 600211.SH |
| Listed Date | 7/21/1999 |
| Chairman | Chen Dabin. |
| CEO | Guo Yuandong. |
| Website | www.xzyy.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
